
TSE:JWEL
This summary was created by AI, based on 2 opinions in the last 12 months.
Jamieson Wellness, a Windsor ON-based company, has gained prominence in the market due to its strategic acquisitions and expansion into international markets like China. With a strong focus on quality, the company has differentiated itself from competitors, making it a sought-after investment for those looking to bolster their portfolios. Analysts suggest that the stock has a positive trajectory, supported by a consistent 14% dividend growth over the past five years and a current yield of 2.55%. Additionally, the stock is seen as a good performer following a recovery from its 2023 low, showing a defined uptrend characterized by higher highs and higher lows. The consensus price target of $42.43 indicates confidence in the stock's potential for future growth.
It is the most prominent name in wellness and vitamins. This company is becoming globally entrenched, but it is very Canadian. It will carry on growing. It has had great numbers. They are at the low end of the price range as holistic people would be willing to pay three times more for the pills. He thinks it has growth potential. (Analysts’ target: $22.25).
It is the MacDonald’s of the vitamin business. It is the number one Canadian consumer health brand. They have more market share than their 5 biggest peers combined. They have exposure in China. He thinks it will be a success-IPO story like DOL-T. It is now going to be a show-me story as they grow their top line.
(A Top Pick July 20/17, Up 56%) He looks for companies that dominate their market. This is the number one consumer healthcare brand. More than the next 5 largest competitors combined. It was a show-me story at the time. It needs to penetrate other geographical markets like China for continued growth. It is fairly valued at this price.